| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0008 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |